IRIS Accounts Production v25.1.3.33 09964264 Board of Directors 1.2.24 31.1.25 31.1.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099642642024-01-31099642642025-01-31099642642024-02-012025-01-31099642642023-01-31099642642023-02-012024-01-31099642642024-01-3109964264ns15:EnglandWales2024-02-012025-01-3109964264ns14:PoundSterling2024-02-012025-01-3109964264ns10:Director12024-02-012025-01-3109964264ns10:PrivateLimitedCompanyLtd2024-02-012025-01-3109964264ns10:SmallEntities2024-02-012025-01-3109964264ns10:AuditExempt-NoAccountantsReport2024-02-012025-01-3109964264ns10:SmallCompaniesRegimeForDirectorsReport2024-02-012025-01-3109964264ns10:SmallCompaniesRegimeForAccounts2024-02-012025-01-3109964264ns10:FullAccounts2024-02-012025-01-3109964264ns10:Director22024-02-012025-01-3109964264ns10:RegisteredOffice2024-02-012025-01-3109964264ns5:CurrentFinancialInstruments2025-01-3109964264ns5:CurrentFinancialInstruments2024-01-3109964264ns5:ShareCapital2025-01-3109964264ns5:ShareCapital2024-01-3109964264ns5:RetainedEarningsAccumulatedLosses2025-01-3109964264ns5:RetainedEarningsAccumulatedLosses2024-01-3109964264ns5:ComputerEquipment2024-02-012025-01-3109964264ns5:ComputerEquipment2024-01-3109964264ns5:ComputerEquipment2025-01-3109964264ns5:ComputerEquipment2024-01-3109964264ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3109964264ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-31
REGISTERED NUMBER: 09964264 (England and Wales)









BLENDWORTH MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2025






BLENDWORTH MEDICAL LIMITED (REGISTERED NUMBER: 09964264)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


BLENDWORTH MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2025







DIRECTORS: Dr M D Coombe
Mrs N Coombe





REGISTERED OFFICE: Station House
North Street
Havant
Hampshire
PO9 1QU





REGISTERED NUMBER: 09964264 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

BLENDWORTH MEDICAL LIMITED (REGISTERED NUMBER: 09964264)

BALANCE SHEET
31 JANUARY 2025

2025 2024
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 803 -

CURRENT ASSETS
Debtors 5 2,800 4,506
Cash at bank 59,488 113,878
62,288 118,384
CREDITORS
Amounts falling due within one year 6 3,264 6,140
NET CURRENT ASSETS 59,024 112,244
TOTAL ASSETS LESS CURRENT
LIABILITIES

59,827

112,244

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 59,727 112,144
SHAREHOLDERS' FUNDS 59,827 112,244

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 May 2025 and were signed on its behalf by:





Dr M D Coombe - Director


BLENDWORTH MEDICAL LIMITED (REGISTERED NUMBER: 09964264)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

1. STATUTORY INFORMATION

Blendworth Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net sales of goods and services during the year, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Deferred tax
Deferred tax is recognised in respect of all timing differences at the balance sheet date, except as otherwise required in the paragraphs below.

Unrelieved losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax shall not be recognised on permanent differences, other than a business combination where assets (other than goodwill) give rise to an deferred tax asset or liability.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

BLENDWORTH MEDICAL LIMITED (REGISTERED NUMBER: 09964264)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2025

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 February 2024 1,239
Additions 1,199
Disposals (1,239 )
At 31 January 2025 1,199
DEPRECIATION
At 1 February 2024 1,239
Charge for year 396
Eliminated on disposal (1,239 )
At 31 January 2025 396
NET BOOK VALUE
At 31 January 2025 803
At 31 January 2024 -

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 2,800 4,506

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other creditors 3,264 6,140